GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carilex Medical Inc (ROCO:7726) » Definitions » YoY EBITDA Growth

Carilex Medical (ROCO:7726) YoY EBITDA Growth : -46.23% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Carilex Medical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Carilex Medical's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -46.23%.

Carilex Medical's EBITDA per Share for the six months ended in Jun. 2024 was NT$1.36.


Carilex Medical YoY EBITDA Growth Historical Data

The historical data trend for Carilex Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carilex Medical YoY EBITDA Growth Chart

Carilex Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -31.53 -22.22 31.92

Carilex Medical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial - - 46.26 18.01 -46.23

Carilex Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Carilex Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(4.327-3.28)/ | 3.28 |
=31.92 %

Carilex Medical's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(1.355-2.52)/ | 2.52 |
=-46.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carilex Medical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Carilex Medical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Carilex Medical Business Description

Traded in Other Exchanges
N/A
Address
No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.

Carilex Medical Headlines

No Headlines